Maryland HB1435: Health Insurance - Required Coverage - Hormone-Related Care

What the bill says

A bill ENTITLED AN ACT concerning Health Insurance - Required Coverage - Hormone-Related Care FOR the purpose of requiring certain insurers, nonprofit health service plans, and health maintenance organizations to provide certain coverage for hormone-related care, including hormone therapy treatment for perimenopausal and menopausal symptoms; establishing certain requirements and prohibitions related to coverage for hormone-related care; and generally relating to health insurance coverage for hormone-related care…

From the introduced text, February 13, 2026:

A BILL ENTITLED AN ACT concerning Health Insurance - Required Coverage - Hormone-Related Care FOR the purpose of requiring certain insurers, nonprofit health service plans, and health maintenance organizations to provide certain coverage for hormone-related care, including hormone therapy treatment for perimenopausal and menopausal symptoms; establishing certain requirements and prohibitions related to coverage for hormone-related care; and generally relating to health insurance coverage for hormone-related care. BY adding to Article - Insurance Section 15-864 Annotated Code of Maryland (2017 Replacement Volume and 2025 Supplement) Preamble WHEREAS, Perimenopause and menopause are common, medically recognized hormonal transitions experienced by a substantial portion of Maryland's adult population; and WHEREAS, Individuals experiencing perimenopause or menopause frequently seek hormone-related care to manage symptoms that, when untreated, can lead to avoidable emergency visits, repeated diagnostic testing, and long-term health complications; and WHEREAS, Insurance coverage for clinically appropriate perimenopausal and menopausal hormone therapy is inconsistent across carriers, resulting in delays, denials, and unnecessary administrative barriers; and EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW. [Brackets] indicate matter deleted from exist in g l aw . *hb1435* HOUSE BILL 1435 WHEREAS, Ensuring timely access to medically necessary hormone-related care for perimenopausal and menopausal individuals promotes health stability, reduces long-term system costs, and supports the well-being of Maryland residents; and WHEREAS, Establishing uniform statewide standards for hormone-related care is …

Read the full official text

Sponsors

• Ryan Spiegel (D, 17) · primary sponsor
• Christopher Bouchat (R, HD-005)
• Charlotte Crutchfield (D, 19)
• Linda Foley (D, 15)
• Kevin Hornberger (R, HD-035A)
• Anne Kaiser (D, HD-014)
• Aaron Kaufman (D, HD-018)
• April Fleming Miller (R, HD-004)
• April Rose (R, 5)
• Chris Tomlinson (R, 5)
• Teresa Woorman (D, 16)

Latest actions

1. March 13, 2026: Hearing 3/13 at 1:30 p.m.
2. March 13, 2026: Hearing 3/13 at 3:00 p.m.
3. March 13, 2026: Hearing canceled
4. February 13, 2026: Hearing 3/13 at 1:00 p.m.
5. February 13, 2026: First Reading Health

Common questions

What is HB1435?

HB1435 is a bill in the Maryland Legislature (2026 Regular Session): Health Insurance - Required Coverage - Hormone-Related Care.

What does HB1435 do?

In its own words: A bill ENTITLED AN ACT concerning Health Insurance - Required Coverage - Hormone-Related Care FOR the purpose of requiring certain insurers, nonprofit health service plans, and health maintenance organizations to provide certain coverage for hormone-related care, including hormone therapy treatment for perimenopausal and menopausal symptoms; establishing certain requirements and prohibitions related to coverage for hormone-related care; and generally relating to health insurance coverage for hormone-related care…

What is the status of HB1435?

In committee as of March 13, 2026. Latest action: Hearing 3/13 at 1:30 p.m. (March 13, 2026).

Who sponsored HB1435?

Ryan Spiegel (D, 17), with 10 co-sponsors.

Where is the official record for HB1435?

On the Maryland Legislature website: https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb1435?ys=2026RS